Ataxia telangiectasia: more variation at clinical and cellular levels-Reference-Cited by-同舟云学术

Ataxia telangiectasia: more variation at clinical and cellular levels

Published:2014-09-08 Issue:3 Volume:87 Page:199-208
ISSN:0009-9163
Container-title:Clinical Genetics
language:en
Short-container-title:Clin Genet

Author:

Taylor A.M.R.¹,Lam Z.¹,Last J.I.¹,Byrd P.J.¹

Affiliation:

1. School of Cancer Sciences; University of Birmingham; Birmingham UK

Funder

Cancer Research UK

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference56 articles.

1. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more;Shiloh;Nat Rev Mol Cell Biol,2013

2. The RAG2 C-terminus and ATM protect genome integrity by controlling antigen receptor gene cleavage;Chaumeil;Nat Commun,2013

3. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity;Driessen;J Allergy Clin Immunol,2013

4. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours;Reiman;Br J Cancer,2011

5. Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection;Boder;Pediatrics,1958

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and genetic spectrum of Ataxia Telangiectasia Tunisian patients: Bioinformatic analysis unveil mechanisms of ATM variants pathogenicity;International Journal of Biological Macromolecules;2024-10

2. Reduced levels of MRE11 cause disease phenotypes distinct from ataxia telangiectasia-like disorder;Human Molecular Genetics;2024-06-18

3. Case report: Compound heterozygous variants detected by next-generation sequencing in a Tunisian child with ataxia-telangiectasia;Frontiers in Neurology;2024-05-31

4. The fine-tuning of synapse development by oxidative stress and autophagy requires presynaptic ATM kinase;2024-04-25

5. A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors;Molecular Cancer Therapeutics;2024-04-08